| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 15/12/2015 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:DARA | (MM) |
| 11/12/2015 | 22:52 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:DARA | (MM) |
| 11/12/2015 | 22:48 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DARA | (MM) |
| 07/12/2015 | 14:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DARA | (MM) |
| 04/12/2015 | 23:07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:DARA | (MM) |
| 04/12/2015 | 22:51 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:DARA | (MM) |
| 19/11/2015 | 12:10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:DARA | (MM) |
| 02/11/2015 | 23:00 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:DARA | (MM) |
| 02/11/2015 | 22:43 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:DARA | (MM) |
| 25/06/2015 | 21:49 | PR Newswire (US) | Robbins Arroyo LLP: Acquisition of DARA BioSciences, Inc. (DARA) by Midatech Pharma Plc (MTPH) May Not Be in Shareholders' Be... | NASDAQ:DARA | (MM) |
| 16/06/2015 | 19:09 | PR Newswire (US) | Lifshitz & Miller Law Firm Announces Investigation of Bio-Reference Laboratories, Inc., DARA BioSciences, Inc., Dealertrack T... | NASDAQ:DARA | (MM) |
| 12/06/2015 | 00:04 | PR Newswire (US) | SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of DARA BioSciences, Inc. And Encourages In... | NASDAQ:DARA | (MM) |
| 11/06/2015 | 17:00 | PR Newswire (US) | Ryan & Maniskas, LLP Investigation of DARA BioSciences, Inc. | NASDAQ:DARA | (MM) |
| 10/06/2015 | 18:11 | PR Newswire (US) | DARA BIOSCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:DARA | (MM) |
| 04/06/2015 | 16:33 | Business Wire | INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of DARA BioSciences, Inc. of Commencement of an Investigation Reg... | NASDAQ:DARA | (MM) |
| 24/04/2015 | 09:30 | Analyst Ratings Network | DARA Biosciences Now Covered by Analysts at HC Wainright (DARA) | NASDAQ:DARA | (MM) |
| 27/03/2015 | 21:12 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:DARA | (MM) |
| 27/03/2015 | 21:11 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:DARA | (MM) |
| 03/03/2015 | 22:31 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:DARA | (MM) |
| 13/02/2015 | 13:52 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:DARA | (MM) |
| 17/06/2014 | 12:00 | Marketwired | DARA BioSciences Announces Leadership Transition | NASDAQ:DARA | (MM) |
| 16/06/2014 | 13:00 | Marketwired | DARA BioSciences' KRN5500 Granted Orphan Drug Designation by FDA for Treatment of Multiple Myeloma | NASDAQ:DARA | (MM) |
| 03/06/2014 | 14:00 | Business Wire | DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients with an Educational Resource to Improve Side Eff... | NASDAQ:DARA | (MM) |
| 02/06/2014 | 22:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) | NASDAQ:DARA | (MM) |
| 30/05/2014 | 14:46 | Marketwired | DARA BioSciences, Inc. Announces Pricing of $12.5 Million Public Offering | NASDAQ:DARA | (MM) |
| 22/05/2014 | 23:16 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:DARA | (MM) |
| 15/05/2014 | 14:30 | Marketwired | DARA BioSciences Observes National Neuropathy Awareness Week | NASDAQ:DARA | (MM) |
| 15/05/2014 | 12:04 | Edgar (US Regulatory) | Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) | NASDAQ:DARA | (MM) |
| 12/05/2014 | 22:10 | Marketwired | DARA BioSciences Announces First Quarter 2014 Results | NASDAQ:DARA | (MM) |
| 09/05/2014 | 14:30 | Marketwired | DARA BioSciences Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products | NASDAQ:DARA | (MM) |